Compound Famotidine Chewable Tablets in Treatment of Symptoms of Heartburn,sour Regurgitation Due to Acid-Related Disorders: a Randomized, Double-Blind, Active Controlled, Multi-Center Study

CAO Aiping

DOI: https://doi.org/10.19577/j.cnki.issn10074406.2010.05.001

2010-01-01

Abstract:AIM To evaluate the efficacy and safety of compound famotidine chewable tablets in treatment of symptoms of heartburn,sour regurgitation due to acid-related disorders.METHODS It was a randomized,double- blind,active controlled and multi-center study.A total of 240 proper patients were randomized to enter either compound famotidine chewable tablet group(group A) or active drug famotidine group(group B) in 1∶1 ratio.Patients in group A took one famotidine placebo capsule first,then took one compound famotidine chewable tablet when having symptoms. Patients in group B took one famotidine capsule first,then took one compound famotidine placebo chewable tablet when having symptoms.Patients in both groups took study drugs before sleeping if the patients had no symptoms.Daily test drug and active controlled drug were not allowed to more than two.The course was 7 d.Symptoms of heartburn,sour regurgitation and upper abdominal pain should be evaluated before treatment and everyday after treatment.Symptoms were evaluated in 5,10,15,20,30,40,50,60 and 120 min after every drug administration.RESULTS A total of 227 patients completed the study according to the protocol,including 114 in group A and 113 in group B.In the first day,instant remission rate of heartburn in group A 10 and 15 min after drug administration was 31.63%and 44.90%respectively, which was significantly higher than group B(P values were 0.006 7 and 0.037 0,respectively).Instant remission rate of sour regurgitation and upper abdominal pain in group A in every time spot within 10-60 min after drug administration was significantly higher than group B,respectively(P values were all less than 0.05).Instant remission rate of overall symptoms in group A 5 min after drug administration was 17.70%.Instant remission rate in every time spot till 60 min after drug administration was significantly higher than group B(P values were all less than 0.05).Instant remission rate of every symptom in 2nd day to 7th day similar to 1st day.Complete remission time in group A for all symptoms was within 50 min.Complete remission time was(46.57±27.39) and(40.95±22.02) min in 1st day and 2nd day,respectively, which was significantly faster than group B(P values were 0.010 6 and 0.006 2,respectively).There were 7 adverse events found in this study,all in group B.No adverse events were found in group A.CONCLUSION Compound famotidine chewable tablet can result in faster remission of symptoms of heartburn,sour regurgitation and upper abdominal pain due to acid-related disordersas compared with famotidine.